Bradycardia resident survival guide: Difference between revisions
Line 16: | Line 16: | ||
===Common Causes=== | ===Common Causes=== | ||
*[[Cardiomyopathy]] | *[[Cardiomyopathy]] | ||
*[[Carotid sinus hypersensitivity]] | *[[Carotid sinus hypersensitivity]] | ||
*[[ | * Drugs <div class="mw-collapsible-content"> | ||
*[[ | <div class="mw-collapsible mw-collapsed"> | ||
*[[Dronedarone]] | : *[[Diltiazem]] | ||
*[[Flecainide]] | : *[[Amiodarone]] | ||
: *[[Amitriptyline]] | |||
: *[[Beta-blockers]] | |||
: *[[Cardiac glycosides]] | |||
: *[[Clonidine]] | |||
: *[[Dronedarone]] | |||
: *[[Flecainide]] | |||
: *[[Lithium]] | |||
: *[[Methyldopa]] | |||
: *[[Phenothiazines]] | |||
: *[[Procainamide]] | |||
: *[[Propafenone]] | |||
: *[[Quinidine]] | |||
: *[[Reserpine]] | |||
: *[[Verapamil]] | |||
</div></div> | |||
*[[Heart transplant]] | *[[Heart transplant]] | ||
*[[Hypertensive heart disease]] | *[[Hypertensive heart disease]] | ||
Line 31: | Line 43: | ||
*[[Hypothyroidism]] | *[[Hypothyroidism]] | ||
*[[Ischemic heart disease]] | *[[Ischemic heart disease]] | ||
*[[Lyme disease]] | *[[Lyme disease]] | ||
*[[Obstructive sleep apnea]] | *[[Obstructive sleep apnea]] | ||
*[[Pericarditis]] | *[[Pericarditis]] | ||
*[[Rheumatic fever]] | *[[Rheumatic fever]] | ||
*[[Sepsis]] | *[[Sepsis]] | ||
*[[Trauma]] | *[[Trauma]] | ||
*[[Vasovagal syncope]] | *[[Vasovagal syncope]] | ||
*[[Viral myocarditis]] | *[[Viral myocarditis]] | ||
Revision as of 20:06, 2 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]: Associate Editor(s)-in-Chief: Ogheneochuko Ajari, MB.BS, MS [2]
Definition
Sinus bradycardia is defined as a sinus rhythm with a rate below 60 beats per minute.
Causes
Life Threatening Causes
Life-threatening conditions which may result in death or permanent disability within 24 hours if left untreated.
Common Causes
- Heart transplant
- Hypertensive heart disease
- Hypothermia
- Hypothyroidism
- Ischemic heart disease
- Lyme disease
- Obstructive sleep apnea
- Pericarditis
- Rheumatic fever
- Sepsis
- Trauma
- Vasovagal syncope
- Viral myocarditis
Management
Figure 1: Management of patients with Bradycardia
Characterize the symptoms: ❑ Palpitations ❑ Lightheadedness ❑ Dyspnea ❑ Chest pain ❑ Altered mental status | |||||||||||||||||||||||||||||||||||||||||||||||||
Examine the patient: ❑ Heart rate < 50/min
❑ Signs of poor perfusion
| |||||||||||||||||||||||||||||||||||||||||||||||||
Identify and treat underlying cause:
❑ Maintain patent airway; assist breathing as necessary
❑ IV access | |||||||||||||||||||||||||||||||||||||||||||||||||
Persistent bradyarrhythmia causing: ❑ Hypotension? ❑ Acutely altered mental status? ❑ Signs of shock? ❑ Ischemic chest discomfort? ❑ Acute heart failure? | |||||||||||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||||||||||
Atropine
If atropine ineffective Transcutaneous Pacing OR
Epinephrine infusion
| Monitor and observe | ||||||||||||||||||||||||||||||||||||||||||||||||
❑ Expert consultation ❑ Transvenous pacing | |||||||||||||||||||||||||||||||||||||||||||||||||
Algorithm based on the 2010 AHA guidelines for cardiopulmonary resuscitation and emergency cardiovascular care.[1]
Do's
- Prepare for transcutaneous pacing if perfusion is poor
- If atropine is ineffective, pacing should begin
- The use of sodium bicarbonate should be considered for severe metabolic acidosis
- Atropine should be used with caution in the presence of myocardial ischemia because it increases oxygen demand and could worsen the ischemia
Don'ts
- Do not delay pacing if rhythm is Mobitz type II second degree block or third-degree AV block
- Avoid using atropine in hypothermic bradycardia and Mobitz type II/second degree AV block
References
- ↑ Neumar, RW.; Otto, CW.; Link, MS.; Kronick, SL.; Shuster, M.; Callaway, CW.; Kudenchuk, PJ.; Ornato, JP.; McNally, B. (2010). "Part 8: adult advanced cardiovascular life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care". Circulation. 122 (18 Suppl 3): S729–67. doi:10.1161/CIRCULATIONAHA.110.970988. PMID 20956224. Unknown parameter
|month=
ignored (help)